Upfront EGFR-Targeted Therapy for NSCLC

(4:41)

Upfront EGFR-Targeted Therapy

(8:28)

Regimen for LS-SCLC and Upfront Combo Therapy for EGFR-Mutant Lung Cancer - 2024 Lung Cancer OncTalk

(7:6)

Upfront EGFR Therapy in Metastatic Colorectal Cancer

(7:10)

EGFR TKIs for Upfront Treatment of NSCLC

(5:47)

Mechanisms of Resistance to Upfront EGFR-Targeted Therapy

(3:48)

EGFR Therapy as Upfront Colorectal Cancer Treatment

(5:9)

EGFR-Targeted Therapy in NSCLC: First Find the Targets, Then Treat With Precision

(21:41)

Up-front Treatment in EGFR Wild-Type Patients

(16:30)

Options for Up-front Therapy in EGFR-mutant NSCLC

(5:)

Should EGFR TKI Therapy be Continued Beyond Progression?

(2:21)

How Do You Decide and Sequence Treatment for EGFR-Mutated Lung Cancer? - 2024 Lung Cancer OncTalk

(3:45)

EGFR-Mutant Lung Cancer \u0026 Treatment Options | 2023 Living with EGFR-Mutant Lung Cancer Patient Forum

(14:24)

How is Molecular Testing Used to Select Upfront Therapy in Patients with EGFR Mutations?

(5:7)

EGFR-Positive NSCLC: Treatment at Progression

(6:41)

Treatment Options for EGFR-Mutated Lung Cancer: Overview - 2024 Lung Cancer OncTalk

(3:59)

EGFR Mutation and Cancer

(6:2)

Ask the Experts: Clinical Trials within Uncommon EGFR Alterations in NSCLC

(49:58)

Screening EGFR Mutations in Lung Cancer

(21:27)

Dr. Gitlitz on EGFR Exon 20 Insertion Mutations in Lung Cancer

(1:11)